Asian Shares Mostly Lower As IMF Lowers China Growth Forecast

Asian Shares Mostly Lower As IMF Lowers China Growth Forecast
Asian stocks ended mostly lower on Tuesday as investors fretted about the impact of rising interest rates, U.S.-China tensions and Italy’s decision to expand budget deficits. The trade war between China and the United States may intensify after China allowed its currency to slip past a psychological bulwark. The International Monetary Fund has lowered its forecast for Chinese economic growth... Read More

People In The News – Murray Kessler

People In The News – Murray Kessler
Perrigo Company plc (PRGO) has appointed Murray S. Kessler as President, CEO and member of the Board of Directors, effective immediately, replacing Uwe Roehrhoff. Most recently, Kessler served as the Chairman of the Board of Directors and CEO of Lorillard Tobacco Co. Prior to joining Lorillard, he was Vice Chair of Altria Inc. and President and CEO of UST Inc.,... Read More

European Shares Seen Opening Flat After China’s Yuan Move

European Shares Seen Opening Flat After China’s Yuan Move
European stocks may open largely unchanged on Tuesday despite worries about the Sino-U.S. trade war and political turmoil in Europe. The trade war between China and the United States may intensify after China allowed its currency to slip past a psychological bulwark. The International Monetary Fund has lowered its forecast for Chinese economic growth in 2019 to 6.2 percent from... Read More

AFMD Bleeds On Clinical Hold, BHC Gets FDA Nod, MNLO Disappoints

AFMD Bleeds On Clinical Hold, BHC Gets FDA Nod, MNLO Disappoints
Today’s Daily Dose brings you news about clinical hold on Affimed’s AFM11 phase I program; Altimmune’s $25 million registered direct offering; FDA approval of Bausch Health’s BRYHALI Lotion; Menlo’s disappointing phase II trial results of Serlopitant and Recro Pharma’s anticipated make or break event. Read on… Shares of Affimed N.V. (AFMD) plunged 25% in extended trading on Monday, following the... Read More